Clinical trials. Nail-biting time for trials of COX-2 drugs

Science. 2004 Dec 3;306(5702):1673-5. doi: 10.1126/science.306.5702.1673.
No abstract available

Publication types

  • News

MeSH terms

  • Alzheimer Disease / prevention & control*
  • Anticarcinogenic Agents / adverse effects
  • Anticarcinogenic Agents / therapeutic use*
  • Cardiovascular Diseases / chemically induced
  • Celecoxib
  • Controlled Clinical Trials as Topic*
  • Cyclooxygenase Inhibitors / adverse effects
  • Cyclooxygenase Inhibitors / therapeutic use*
  • Humans
  • Intestinal Polyps / prevention & control
  • Lactones / adverse effects
  • Lactones / therapeutic use
  • Neoplasms / prevention & control*
  • Patient Selection
  • Pyrazoles
  • Sulfonamides / adverse effects
  • Sulfonamides / therapeutic use*
  • Sulfones

Substances

  • Anticarcinogenic Agents
  • Cyclooxygenase Inhibitors
  • Lactones
  • Pyrazoles
  • Sulfonamides
  • Sulfones
  • rofecoxib
  • Celecoxib